Price loading...

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Greater China

Price data last checked 104 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications
Format
paperback
ASIN
B00DW08NTA
Category
Books > Subjects > Business, Finance & Law > Economics > Econometrics
Domain
Amazon UK
Release Date
19 May 2013
Listed Since
12 July 2013

Similar Products You Might Like

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Asia
98% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Asia

£325.00 12 Jan 2026
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in the United States
98% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in the United States

£495.00 08 Jan 2026
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Europe
97% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Europe

£325.00 24 Feb 2026
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in India
97% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in India

£495.00 07 Jan 2026
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Japan
97% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Japan

£495.00 15 Feb 2026
The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in China
95% match

The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in China

£495.00 13 Jan 2026
The 2023-2028 Outlook for Diabetes Drugs in China
95% match

The 2023-2028 Outlook for Diabetes Drugs in China

£495.00 13 Dec 2025
The 2023-2028 Outlook for Injectable Diabetes Drugs in China
95% match

The 2023-2028 Outlook for Injectable Diabetes Drugs in China

£495.00 16 Dec 2025
The 2023-2028 Outlook for Kinase Inhibitors in China
95% match

The 2023-2028 Outlook for Kinase Inhibitors in China

£495.00 08 Jan 2026
The 2013-2018 Outlook for Hormone Replacement Therapy (HRT) in Greater China
95% match

The 2013-2018 Outlook for Hormone Replacement Therapy (HRT) in Greater China

£495.00 13 Jan 2026
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in China
95% match

The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in China

£495.00 06 Feb 2026
The 2013-2018 Outlook for Testosterone Replacement Therapy (TRT) in Greater China
95% match

The 2013-2018 Outlook for Testosterone Replacement Therapy (TRT) in Greater China

£495.00 09 Jan 2026
The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in China
95% match

The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in China

£495.00 13 Jan 2026
The 2013-2018 Outlook for Financial Planning Services in Greater China
94% match

The 2013-2018 Outlook for Financial Planning Services in Greater China

£495.00 08 Jan 2026
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in China
94% match

The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in China

£495.00 26 Jan 2026
The 2023-2028 Outlook for Lipopeptide MRSA Drugs in China
94% match

The 2023-2028 Outlook for Lipopeptide MRSA Drugs in China

£495.00 01 Feb 2026
The 2013-2018 Outlook for Human Papilloma Virus (HPV) Testing in Greater China
94% match

The 2013-2018 Outlook for Human Papilloma Virus (HPV) Testing in Greater China

£495.00 06 Jan 2026
The 2013-2018 Outlook for Encryption Software in Greater China
94% match

The 2013-2018 Outlook for Encryption Software in Greater China

£495.00 05 Feb 2026
The 2023-2028 Outlook for Human Insulin Drugs in China
94% match

The 2023-2028 Outlook for Human Insulin Drugs in China

£495.00 13 Jan 2026
The 2013-2018 Outlook for Small Molecule Kinase Inhibitors in North America & the Caribbean
94% match

The 2013-2018 Outlook for Small Molecule Kinase Inhibitors in North America & the Caribbean

£325.00 29 Jan 2026
The 2023-2028 Outlook for GLP-1 Agonists for Type 2 Diabetes in China
94% match

The 2023-2028 Outlook for GLP-1 Agonists for Type 2 Diabetes in China

£495.00 06 Feb 2026
The 2013-2018 Outlook for Mail Orders in Greater China
94% match

The 2013-2018 Outlook for Mail Orders in Greater China

£495.00 07 Feb 2026
The 2023-2028 Outlook for Anti-Malarial Drugs in China
94% match

The 2023-2028 Outlook for Anti-Malarial Drugs in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Drug Delivery Products in China
94% match

The 2023-2028 Outlook for Drug Delivery Products in China

£495.00 14 Jan 2026